Vascepa Alternatives
Drugs like Vascepa (icosapent ethyl) — other cardiovascular medications advertised on TV that may be alternatives. Informational only — not medical advice. Only your doctor can decide what's right for you.
Unverified catalogue summary (alternative grouping) for Vascepa in US; not checked against current local product information.
Eliquis
apixaban · Bristol-Myers Squibb/Pfizer
Treats Blood clots, nonvalvular atrial fibrillation
Unverified catalogue summary (alternative identity, manufacturer and indication) for Eliquis in US; not checked against current local product information.
Xarelto
rivaroxaban · Janssen Pharmaceuticals, Inc.
Treats Blood clots, nonvalvular atrial fibrillation
Unverified catalogue summary (alternative identity, manufacturer and indication) for Xarelto in US; not checked against current local product information.
Entresto
sacubitril/valsartan · Novartis
Treats Chronic heart failure
Unverified catalogue summary (alternative identity, manufacturer and indication) for Entresto in US; not checked against current local product information.
Repatha
evolocumab · Amgen
Treats High cholesterol, cardiovascular disease
Unverified catalogue summary (alternative identity, manufacturer and indication) for Repatha in US; not checked against current local product information.
Brilinta
ticagrelor · AstraZeneca Pharmaceuticals LP (US distributor)
Treats Acute coronary syndrome, heart attack prevention
Unverified catalogue summary (alternative identity, manufacturer and indication) for Brilinta in US; not checked against current local product information.
Leqvio
inclisiran · Novartis
Treats High cholesterol
Unverified catalogue summary (alternative identity, manufacturer and indication) for Leqvio in US; not checked against current local product information.
Lipitor
atorvastatin · Viatris Specialty LLC (US distributor)
Treats High cholesterol, cardiovascular prevention
Unverified catalogue summary (alternative identity, manufacturer and indication) for Lipitor in US; not checked against current local product information.
Crestor
rosuvastatin · AstraZeneca Pharmaceuticals LP (US distributor)
Treats High cholesterol, cardiovascular prevention
Unverified catalogue summary (alternative identity, manufacturer and indication) for Crestor in US; not checked against current local product information.
Lisinopril
lisinopril · Various (generic)
Treats High blood pressure, heart failure
Unverified catalogue summary (alternative identity, manufacturer and indication) for Lisinopril in US; not checked against current local product information.
Vyndamax
tafamidis · Pfizer
Treats Transthyretin amyloid cardiomyopathy
Unverified catalogue summary (alternative identity, manufacturer and indication) for Vyndamax in US; not checked against current local product information.
Camzyos
mavacamten · Bristol-Myers Squibb
Treats Obstructive hypertrophic cardiomyopathy
Unverified catalogue summary (alternative identity, manufacturer and indication) for Camzyos in US; not checked against current local product information.
Winrevair
sotatercept-csrk · Merck Sharp & Dohme LLC
Treats Pulmonary arterial hypertension
Unverified catalogue summary (alternative identity, manufacturer and indication) for Winrevair in US; not checked against current local product information.
Sources and editorial standards
Product-label references, not clinical verification. Medicine identification—not prescribing guidance. This page does not provide a complete safety or dosing reference. Check the official label for your country and exact product, and consult your pharmacist or prescriber before starting, stopping or changing treatment. Missing information does not mean a medicine is safe for you. Reference formulation scope (not dosing instructions): VASCEPA icosapent ethyl oral soft-gelatin capsules, 0.5 and 1 gram
Unresolved / not established by these sources:
- Clinical summaries, safety tiers and dosing guidance are withheld while their review remains unfinished.
- A linked document may have been superseded. Confirm country, product, formulation and latest revision with the regulator or pharmacist.
- US label reference: Vascepa US prescribing information — identity, company attribution and initial approval
Manufacturer label · Reference scope: Reference link only. Verify the exact formulation and current revision; this does not certify a clinical summary.
Lookup resources (not product-specific citations; confirm formulation and country before use):
- DailyMed current labels for Vascepa
- DailyMed current labels for Eliquis
- DailyMed current labels for Xarelto
- DailyMed current labels for Entresto
- DailyMed current labels for Repatha
- DailyMed current labels for Brilinta
- DailyMed current labels for Leqvio
- DailyMed current labels for Lipitor
- DailyMed current labels for Crestor
- DailyMed current labels for Lisinopril
- DailyMed current labels for Vyndamax
- DailyMed current labels for Camzyos
- DailyMed current labels for Winrevair
- FDA drug approvals and databases
- How TVPills researches and reviews content
Frequently asked questions
What drugs are similar to Vascepa?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Drugs like Vascepa include other cardiovascular medications advertised on TV such as Eliquis, Xarelto, Entresto and more. This is an editorial catalogue grouping, not a verified comparison of indications, safety or suitable substitutes. Ask your prescriber about treatment choices.
What can I take instead of Vascepa?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Other cardiovascular medications advertised on TV include Eliquis, Xarelto, Entresto and others. The right alternative depends on your diagnosis, medical history and insurance — only your doctor can recommend a substitute for Vascepa. This page is informational only.
Is there a generic version of Vascepa?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Vascepa is sold as icosapent ethyl. Whether a lower-cost generic is available depends on patent status — ask your pharmacist, and see the cost & savings page for ways to pay less.
Are these alternatives the same as Vascepa?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. This catalogue grouping does not establish therapeutic equivalence, shared approved indications or suitability as a substitute. Do not switch medicines based on it; consult your prescriber.